Characteristics and outcomes of atrial fibrillation in patients without traditional risk factors: an RE-LY AF registry analysis.

Atrial fibrillation hospitalization Borderline risk factors Less-established risk factors Lone atrial fibrillation Registry Substrate

Journal

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
ISSN: 1532-2092
Titre abrégé: Europace
Pays: England
ID NLM: 100883649

Informations de publication

Date de publication:
01 06 2020
Historique:
received: 11 10 2019
accepted: 12 12 2019
pubmed: 28 3 2020
medline: 29 6 2021
entrez: 28 3 2020
Statut: ppublish

Résumé

Data on patient characteristics, prevalence, and outcomes of atrial fibrillation (AF) patients without traditional risk factors, often labelled 'lone AF', are sparse. The RE-LY AF registry included 15 400 individuals who presented to emergency departments with AF in 47 countries. This analysis focused on patients without traditional risk factors, including age ≥60 years, hypertension, coronary artery disease, heart failure, left ventricular hypertrophy, congenital heart disease, pulmonary disease, valve heart disease, hyperthyroidism, and prior cardiac surgery. Patients without traditional risk factors were compared with age- and region-matched controls with traditional risk factors (1:3 fashion). In 796 (5%) patients, no traditional risk factors were present. However, 98% (779/796) had less-established or borderline risk factors, including borderline hypertension (130-140/80-90 mmHg; 47%), chronic kidney disease (eGFR < 60 mL/min; 57%), obesity (body mass index > 30; 19%), diabetes (5%), excessive alcohol intake (>14 units/week; 4%), and smoking (25%). Compared with patients with traditional risk factors (n = 2388), patients without traditional risk factors were more often men (74% vs. 59%, P < 0.001) had paroxysmal AF (55% vs. 37%, P < 0.001) and less AF persistence after 1 year (21% vs. 49%, P < 0.001). Furthermore, 1-year stroke occurrence rate (0.6% vs. 2.0%, P = 0.013) and heart failure hospitalizations (0.9% vs. 12.5%, P < 0.001) were lower. However, risk of AF-related re-hospitalization was similar (18% vs. 21%, P = 0.09). Almost all patients without traditionally defined AF risk factors have less-established or borderline risk factors. These patients have a favourable 1-year prognosis, but risk of AF-related re-hospitalization remains high. Greater emphasis should be placed on recognition and management of less-established or borderline risk factors.

Identifiants

pubmed: 32215649
pii: 5812145
doi: 10.1093/europace/euz360
pmc: PMC7273333
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

870-877

Subventions

Organisme : CIHR
Pays : Canada

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.

Références

Nat Rev Cardiol. 2016 Jul 14;13(8):501
pubmed: 27411521
Circulation. 2007 Jun 19;115(24):3050-6
pubmed: 17548732
Europace. 2018 Nov 1;20(11):1750-1757
pubmed: 29518195
Eur Heart J. 2006 Feb;27(3):357-64
pubmed: 16275661
Circulation. 2014 Apr 15;129(15):1568-76
pubmed: 24463370
Eur Heart J. 1999 Jun;20(12):896-9
pubmed: 10329095
J Am Coll Cardiol. 2014 May 6;63(17):1715-23
pubmed: 24530673
Eur Heart J. 2018 Aug 21;39(32):2987-2996
pubmed: 29401239
Europace. 2013 Jan;15(1):18-23
pubmed: 22782972
N Engl J Med. 1987 Sep 10;317(11):669-74
pubmed: 3627174
Eur Heart J. 2016 May 21;37(20):1591-602
pubmed: 26888184
J Interv Card Electrophysiol. 2005 Sep;13(3):203-7
pubmed: 16177847
Heart Lung Circ. 2017 Sep;26(9):990-997
pubmed: 28662919
Europace. 2012 Feb;14(2):184-90
pubmed: 22135317
Am Heart J. 2017 Mar;185:74-84
pubmed: 28267478
Lancet. 2016 Sep 17;388(10050):1161-9
pubmed: 27515684
JAMA. 1985 Dec 27;254(24):3449-53
pubmed: 4068186
Br Heart J. 1954 Apr;16(2):189-94
pubmed: 13160271
Circulation. 2017 Aug 8;136(6):583-596
pubmed: 28784826
Europace. 2016 Nov;18(11):1609-1678
pubmed: 27567465

Auteurs

Mariëlle Kloosterman (M)

Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Jonas Oldgren (J)

Department of Medical Sciences, Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.

David Conen (D)

Population Health Research Institute, Department of Medicine, McMaster University, 30 Birge St. Room C3-121, Hamilton, Ontario L8L 0A6, Canada.

Jorge A Wong (JA)

Population Health Research Institute, Department of Medicine, McMaster University, 30 Birge St. Room C3-121, Hamilton, Ontario L8L 0A6, Canada.

Stuart J Connolly (SJ)

Population Health Research Institute, Department of Medicine, McMaster University, 30 Birge St. Room C3-121, Hamilton, Ontario L8L 0A6, Canada.

Alvaro Avezum (A)

Division of Cardiology, Dante Pazzanese Institute of Cardiology, Sao Paulo, Brazil.

Salim Yusuf (S)

Population Health Research Institute, Department of Medicine, McMaster University, 30 Birge St. Room C3-121, Hamilton, Ontario L8L 0A6, Canada.

Michael D Ezekowitz (MD)

Department of Medicine, Medical College and Lankenau Medical Center, Wynnewood, PA, USA.

Lars Wallentin (L)

Department of Medical Sciences, Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.

Marie Ntep-Gweth (M)

Department of Medicine, Hôpital Central de Yaoundé, Yaounde, Cameroon.

Philip Joseph (P)

Population Health Research Institute, Department of Medicine, McMaster University, 30 Birge St. Room C3-121, Hamilton, Ontario L8L 0A6, Canada.

Tyler W Barrett (TW)

Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Supachai Tanosmsup (S)

Department of Medicine, Mahidol University, Bangkok, Thailand.

William F McIntyre (WF)

Population Health Research Institute, Department of Medicine, McMaster University, 30 Birge St. Room C3-121, Hamilton, Ontario L8L 0A6, Canada.

Shun Fu Lee (SF)

Population Health Research Institute, Department of Medicine, McMaster University, 30 Birge St. Room C3-121, Hamilton, Ontario L8L 0A6, Canada.

Ratika Parkash (R)

Department of Medicine, Queen Elizabeth II Health Sciences Center and Dalhousie University, Halifax, Nova Scotia, Canada.

Guy Amit (G)

Population Health Research Institute, Department of Medicine, McMaster University, 30 Birge St. Room C3-121, Hamilton, Ontario L8L 0A6, Canada.

Alex Grinvalds (A)

Population Health Research Institute, Department of Medicine, McMaster University, 30 Birge St. Room C3-121, Hamilton, Ontario L8L 0A6, Canada.

Isabelle C Van Gelder (IC)

Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Jeff S Healey (JS)

Population Health Research Institute, Department of Medicine, McMaster University, 30 Birge St. Room C3-121, Hamilton, Ontario L8L 0A6, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH